Abstract
Transplantable experimental tumor models were constructed to study the activities of recombinant human interleukin-15 (rhIL-15) against tumor recurrence and metastasis. The results showed that tumor nodule formation was retarded and tumor growth was inhibited in the subcutaneous tumor model of LA795 lung adenocarcinoma after treatment with rhIL-15, and the survival rate of T739 tumor-bearing mice treated with rhIL-15 was much higher than that of mice treated with either saline or with the same dose of rhIL-2. This indicats that rhIL-15 had better antitumor effect than rhIL-2 at the same dose level. In some rhIL-15 treated mice, the tumor cells inoculated subcutaneously were eradicated and there was no tumor formation even 138 days after tumor cell inoculation. The tumor-free mice were rechallenged with live tumor cells and no tumor reoccurred in the following two months in all of these mice, indicating that long-lasting antitumor systemic immunity developed. It was also shown that tumor recurrence and metastasis were inhibited markedly after treatment with rhIL-15, but not with the same dose of rhIL-2, in both subcutaneously and intravenously disseminated tumor models of LA795 lung adenocarcinoma. Simultaneously, the CTL and NK cell activities of the splenocytes obtained from tumor-bearing mice that had been treated with either rhIL-15 or rhIL-2 were both markedly enhanced. However, the enhancement of CTL and NK cell activities was more significant in rhIL-15 treated mice than that in rhIL-2 treated mice. This suggests that the anti-tumor effect of rhIL-15 in vivo was achieved by enhancing the CTL and NK cell activities in tumor immune response.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, F., Zhao, L., Jiang, Y. et al. Activity of Recombinant Human Interleukin-15 against Tumor Recurrence and Metastasis in Mice. Cell Mol Immunol 5, 189–196 (2008). https://doi.org/10.1038/cmi.2008.23
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2008.23
Keywords
This article is cited by
-
Exercise in advanced prostate cancer elevates myokine levels and suppresses in-vitro cell growth
Prostate Cancer and Prostatic Diseases (2022)
-
Exploring the NK cell platform for cancer immunotherapy
Nature Reviews Clinical Oncology (2021)
-
Exercise-induced myokines and their effect on prostate cancer
Nature Reviews Urology (2021)
-
Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model
BMC Cancer (2015)
-
A novel immunocompetent murine tumor model for the evaluation of RCAd-enhanced RDAd transduction efficacy
Tumor Biology (2012)